Newly published research in The Lancet Oncology lays the foundation for many patients with head and neck cancers to be treated with tailored therapies that are less invasive and to avoid major, potentially debilitating surgeries.
A University of California, Irvine, research team has developed and implemented an intervention to enhance cancer care support services for racial and ethnic minority patients undergoing chemotherapy.
A comprehensive study by Karolinska Institutet found no evidence that GLP-1 analogs increase the risk of thyroid cancer. Analyzing data from over 435,000 patients across...
There's a frustrating fact about today's immunotherapies for cancer. While sometimes they work beautifully -; completely eliminating or greatly reducing cancer in particular patients -; other times they don't work at all. It's a mystery.
A new study unveiled a groundbreaking approach to predicting the effectiveness of treatments for patients with Diffuse Large B-Cell Lymphoma (DLBCL), a common form of blood cancer.
A study led by researchers at Brighton and Sussex Medical School (BSMS) has unveiled an approach to predicting the effectiveness of treatments for patients with diffuse large B-cell lymphoma (DLBCL), a common form of blood cancer.
The research received funding from AstraZeneca, Prostate Cancer UK, Cancer Research UK, the Medical Research Council, Movember and the Prostate Cancer Foundation
The research received funding from AstraZeneca, Prostate Cancer UK, Cancer Research UK, the Medical Research Council, Movember and the Prostate Cancer Foundation
(MedPage Today) -- Women with early-stage breast cancer who couldn't enter clinical trials of cryoablation because of "unfavorable" tumor or patient characteristics nevertheless enjoyed a high rate of treatment success and few adverse…
A host of stars have joined Dead Ringers co-creator and prostate cancer patient Jon Holmes to share gory details of their illnesses and get men talking. It's all about finding humour in the darkest of places, explains the broadcaster and…